Untargeted Metabolomic Analysis of Amniotic Fluid in the Prediction of Preterm Delivery and Bronchopulmonary Dysplasia

Untargeted Metabolomic Analysis of Amniotic Fluid in the Prediction of Preterm Delivery and Bronchopulmonary Dysplasia

Bibliographic Details
Main Authors:	Baraldi, Eugenio, Giordano, Giuseppe, Stocchero, Matteo, Moschino, Laura, Zaramella, Patrizia, Tran, Maria Rosa, Carraro, Silvia, Romero, Roberto, Gervasi, Maria Teresa
Format:	Online
Language:	English
Published:	Public Library of Science 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068788/

Similar Items

Untargeted metabolomics: an emerging approach to determine the composition of herbal products
by: Commisso, Mauro, et al.
Published: (2013)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
by: Rivera, Lidys, et al.
Published: (2016)

Initial respiratory management in preterm infants and bronchopulmonary dysplasia
by: López, Ester Sanz, et al.
Published: (2011)

Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates
by: Trittmann, J. K., et al.
Published: (2013)

Vitamin D and bronchopulmonary dysplasia in preterm infants
by: Joung, K E, et al.
Published: (2016)

Association between anemia and bronchopulmonary dysplasia in preterm infants
by: Duan, Jun, et al.
Published: (2016)

Oxidative Stress and Bronchopulmonary Dysplasia
by: Perrone, Serafina, et al.
Published: (2012)

Association between Red Blood Cell Transfusion and Bronchopulmonary Dysplasia in Preterm Infants
by: Zhang, Zhiqun, et al.
Published: (2014)

Gene Expression Profiling in Preterm Infants: New Aspects of Bronchopulmonary Dysplasia Development
by: Pietrzyk, Jacek J., et al.
Published: (2013)

Vitamin D and IL-10 Deficiency in Preterm Neonates With Bronchopulmonary Dysplasia
by: Xiaonan Mao, et al.
Published: (2018-09-01)

Lung function development after preterm birth in relation to severity of Bronchopulmonary dysplasia
by: Petra Um-Bergström, et al.
Published: (2017-06-01)

Carboxyhemoglobin Formation in Preterm Infants Is Related to the Subsequent Development of Bronchopulmonary Dysplasia
by: Tokuriki, Shuko, et al.
Published: (2015)

Bronchopulmonary Dysplasia in Preterm Infants Born at Less Than 32 Weeks Gestation
by: Xu, Yan-Ping
Published: (2016)

Incidence of Bronchopulmonary Dysplasia in Korea
by: Choi, Chang Won, et al.
Published: (2012)

Correlation of retinopathy of prematurity with bronchopulmonary dysplasia
by: Podraza Wojciech, et al.
Published: (2018-03-01)

Impact of bronchopulmonary dysplasia on brain and retina
by: Poon, Annie Wing Hoi, et al.
Published: (2016)

Hospital management of severe bronchopulmonary dysplasia
by: Moretti, Corrado, et al.
Published: (2015)

Pulmonary Hemosiderosis in Children with Bronchopulmonary Dysplasia
by: Kurahara, David, et al.
Published: (2014)

Dissecting Bottromycin Biosynthesis Using Comparative Untargeted Metabolomics
by: Crone, William J. K., et al.
Published: (2016)

Untargeted Metabolomics To Ascertain Antibiotic Modes of Action
by: Vincent, Isabel M., et al.
Published: (2016)

Improved batch correction in untargeted MS-based metabolomics
by: Wehrens, Ron, et al.
Published: (2016)

Analytical Methods in Untargeted Metabolomics: State of the Art in 2015
by: Alonso, Arnald, et al.
Published: (2015)

Respiratory outcomes and atopy in school-age children who were preterm at birth, with and without bronchopulmonary dysplasia
by: Guimarães, Hercília, et al.
Published: (2011)

Stable Isotope-Assisted Evaluation of Different Extraction Solvents for Untargeted Metabolomics of Plants
by: Doppler, Maria, et al.
Published: (2016)

Current Pharmacologic Approaches for Prevention and Treatment of Bronchopulmonary Dysplasia
by: Tropea, Kristen, et al.
Published: (2012)

HLA and Bronchopulmonary Dysplasia Susceptibility: A Pilot Study
by: Rocha, Gustavo, et al.
Published: (2011)

Genetic and Epidemiological Risk Factors in the Development of Bronchopulmonary Dysplasia
by: Mailaparambil, Beena, et al.
Published: (2010)

Bronchopulmonary dysplasia - an overview about pathophysiologic concepts
by: Niedermaier, Sophie, et al.
Published: (2015)

S-Nitrosoglutathione Attenuates Airway Hyperresponsiveness in Murine Bronchopulmonary Dysplasia
by: Raffay, Thomas M., et al.
Published: (2016)

Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia
by: Möbius, Marius A., et al.
Published: (2016)

The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and Source
by: Mižíková, Ivana, et al.
Published: (2015)

The efficacy and safety of Montelukast sodium in the prevention of bronchopulmonary dysplasia
by: Kim, Sang Bum, et al.
Published: (2015)

Drug therapy for the prevention and treatment of bronchopulmonary dysplasia
by: Iyengar, Anjali, et al.
Published: (2015)

Inhaled Bronchodilator Use for Infants with Bronchopulmonary Dysplasia
by: Slaughter, Jonathan L, et al.
Published: (2014)

Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
by: Slaughter, Jonathan L., et al.
Published: (2014)

Circulating Fibrocytes Are Increased in Neonates with Bronchopulmonary Dysplasia
by: Li, Chun, et al.
Published: (2016)

Aberrant Pulmonary Vascular Growth and Remodeling in Bronchopulmonary Dysplasia
by: Alvira, Cristina M.
Published: (2016)

Development of a proxy-reported pulmonary outcome scale for preterm infants with bronchopulmonary dysplasia
by: Massie, Sara E, et al.
Published: (2011)

Cytomegalovirus infection associated with atypical bronchopulmonary dysplasia in a preterm neonate: a case report
by: Zainudin, Zurina, et al.
Published: (2018)

Early Respiratory Management of Respiratory Distress Syndrome in Very Preterm Infants and Bronchopulmonary Dysplasia: A Case-Control Study
by: te Pas, Arjan B., et al.
Published: (2007)